- Investopedia•23 hours ago
Biotech M&A activity has fallen.
- Motley Fool•4 days ago
Tesaro has set the price of its newly launched PARP inhibitor, Zejula, at nearly $10,000 per month.
- MarketWatch•4 days ago
The price is “a sticker shock” but will probably come closer to $119,000-a-year, one analyst said.
TSRO : Summary for TESARO, Inc. - Yahoo Finance
Tesaro, Inc. (TSRO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Ask||162.00 x 100|
|Day's Range||135.23 - 138.00|
|52 Week Range||36.68 - 192.94|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-16.87|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|